abstract |
The present invention discloses neutralizing antibodies that specifically bind to HIV-1 Env and antigen-binding fragments of these antibodies. Nucleic acids, vectors and host cells encoding these antibodies are also provided. Methods for detecting HIV-1 using these antibodies are disclosed. Additionally, the use of these antibodies, antigen-binding fragments, nucleic acids and vectors to prevent and/or treat HIV-1 infection is disclosed. |